Related Experiment Video
Updated: Sep 18, 2026

Non-Invasive Model of Neuropathogenic Escherichia coli Infection in the Neonatal Rat
Published on: October 29, 2014
The influence of killed Propionibacterium granulosum on experimental infection with Escherichia coli
Abstract:
Mice infected subcutaneously with 5 X 10(3) viable cells of Escherichia coli ATCC 25922 incorporated in liquified agar developed a systemic infection. Increasing bacterial numbers could be recovered from the liver at several days following infection. Ultimately, the animals died 6 days after infection. Treatment of mice with 1 mg killed Propionibacterium granulosum KP-45 lead to an increased spleen weight at day 7 after intraperitoneal injection. Hence, the animals were highly susceptible to the lethal action of endotoxin. They were, however, markedly protected against infection with E. coli, since definitely lower bacterial counts were found in the liver of pretreated mice in comparison to controls.
Insights
Propionibacterium granulosum pretreatment protected mice against lethal Escherichia coli infection, reducing bacterial liver counts. This immunotherapy enhanced resistance to bacterial systemic infection.
Area of Science:
- Immunology
- Microbiology
- Infectious Diseases
Background:
- Systemic infections caused by Escherichia coli can be lethal.
- The use of bacterial components as immunomodulators is an area of research.
Purpose of the Study:
- To investigate the protective effect of killed Propionibacterium granulosum KP-45 against Escherichia coli infection in mice.
Main Methods:
- Mice were infected subcutaneously with Escherichia coli ATCC 25922.
- Mice were pretreated intraperitoneally with killed Propionibacterium granulosum KP-45.
- Bacterial counts in the liver and spleen weight were assessed.
Main Results:
- Escherichia coli infection led to systemic infection and death in mice within 6 days.
- Pretreatment with Propionibacterium granulosum KP-45 increased spleen weight.
- Pretreated mice showed significantly lower bacterial counts in the liver compared to controls, indicating protection.
Conclusions:
- Killed Propionibacterium granulosum KP-45 confers protection against systemic Escherichia coli infection in mice.
- This suggests a potential immunotherapeutic strategy for bacterial infections.
Related Concept Videos
Colonisation of Pathogens
Determinants of Bacterial Pathogenicity and Virulence

